ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1,287 Cr | ₹1,165 Cr | ₹1,137 Cr | ₹1,144 Cr | ₹150 Cr |
What is the latest Contingent Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹1,287 Cr |
| Mar2025 | ₹1,165 Cr |
| Mar2024 | ₹1,137 Cr |
| Mar2023 | ₹1,144 Cr |
| Mar2022 | ₹150 Cr |
How is Contingent Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,287 Cr | 10.52 | |
| Mar2025 | ₹1,165 Cr | 2.44 | |
| Mar2024 | ₹1,137 Cr | -0.61 | |
| Mar2023 | ₹1,144 Cr | 661.47 | |
| Mar2022 | ₹150 Cr | - | |
Compare Contingent Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,556.7 Cr | 2.4% | 10.4% | -10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 2.4% |
10.4% |
-10.6% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses